Abstract:Abstract Background Tissue damage and cellular destruction are the major events in traumatic brain injury (TBI), which trigger sterile neuroimmune and neuroinflammatory responses in the brain. While appropriate acute and transient neuroimmune and neuroinflammatory responses facilitate the repair and adaptation of injured brain tissues, prolonged and excessive neuroimmune and neuroinflammatory responses exacerbate brain damage. The mechanisms that control the intensity and duration of neuroimmune and neuroinflammatory responses in TBI largely remain elusive. Methods We used the controlled cortical impact (CCI) model of TBI to study the role of immune checkpoints (ICPs), key regulators of immune homeostasis, in the regulation of neuroimmune and neuroinflammatory responses in the brain in vivo . Results We found that de novo expression of PD-L1, a potent inhibitory ICP, was robustly and transiently induced in reactive astrocytes, but not in microglia, neurons, or oligodendrocyte progenitor cells (OPCs). These PD-L1 + reactive astrocytes were highly enriched to form a dense zone around the TBI lesion. Blockade of PD-L1 signaling enlarged brain tissue cavity size, increased infiltration of inflammatory Ly-6C High monocytes/macrophages (M/M ɸ ) but not tissue-repairing Ly-6C Low F4/80 + M/M ɸ , and worsened TBI outcomes in mice. PD-L1 gene knockout enhanced production of CCL2 that is best known for its ability to interact with its cognate receptor CCR2 on Ly-6C High M/M φ to chemotactically recruit these cells into inflammatory sites. Mechanically, PD-L1 signaling in astrocytes likely exhibits dual inhibitory activities for the prevention of excessive neuroimmune and neuroinflammatory responses to TBI through (1) the PD-1/PD-L1 axis to suppress the activity of brain-infiltrating PD-1 + immune cells, such as PD-1 + T cells, and (2) PD-L1 intrinsic signaling to regulate the timing and intensity of astrocyte reactions to TBI. Conclusions PD-L1 + astrocytes act as a gatekeeper to the brain to control TBI-related neuroimmune and neuroinflammatory responses, thereby opening a novel avenue to study the role of ICP–neuroimmune axes in the pathophysiology of TBI and other neurological disorders.

Molecular Mechanisms and Signaling Pathways of Reactive Astrocytes Responding to Traumatic Brain Injury

CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions

Microglia: A Potential Drug Target for Traumatic Axonal Injury

Dual Roles of Astrocytes in Plasticity and Reconstruction after Traumatic Brain Injury

Reactive gliosis in traumatic brain injury: a comprehensive review

Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury

Progress of Astrocyte Activation and Traumatic Brain Injury Research

Traumatic Brain Injury: Mechanisms of Glial Response

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Neuroimmune and Neuroinflammation Response for Traumatic Brain Injury

Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration.

Neuroinflammation and neurodegeneration following traumatic brain injuries

Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes

Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With Traumatic Brain Injury

Single-cell RNA-sequencing analysis reveals enhanced non-canonical neurotrophic factor signaling in the subacute phase of traumatic brain injury

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?

Integration of single-cell and bulk RNA sequencing data reveals key cell types and regulators in traumatic brain injury

A Pvr–AP-1–Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury

Glial cells react to closed head injury in a distinct and spatiotemporally orchestrated manner

PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury